News

PsychoGenics Awarded an NIH Contract to Test and Identify Novel Therapeutics for Pain

PARAMUS, N.J., October 8, 2024 –– PsychoGenics Inc. (PsychoGenics) today announced it has been awarded a contract by the National Institutes...

News

PsychoGenics Inc. Awarded $3 million SBIR Grant to Employ its AI-enabled Platforms to Find Treatments for Rare Disorders

PARAMUS, NEW JERSEY, August 28, 2024 – PsychoGenics, a leader in AI-enabled phenotypic drug discovery, has been awarded a Fast Track...

News

The Christopher and Dana Reeve Foundation Announces #3.1M Spinal Cord Injury Research Grants

Grant awards to fund novel clinical projects and scientific tools aimed at improving quality of life for individuals impacted by...

News

Unlock New Possibilities with PsychoGenics’ Special Offer!

We’re excited to introduce more clients to our AI-enabled platforms through an exclusive promotion, available throughout the year. Offer Details:...

Partner with us and transform your program

DISCOVER YOUR NEXT BREAKTHROUGH WITH PSYCHOGENICS

Get Started